OTC market in Poland 2017

Market analysis and development forecasts 2017-2022

View Leaflet Free Sample

Industry Report

OTC market in Poland 2017

Market analysis and development forecasts 2017-2022

This product is also available in Polish

Product details

Price:

3 000

Choose language

You don't have to wait. The content will be accessible online at the My PMR account.

OTC market in Poland 2017

Market analysis and development forecasts 2017-2022

View Leaflet Free Sample

An analysis of the OTC market (over-the-counter market for dietary supplements and other products sold) developed by the PMR’s experts includes current market conditions, development forecasts, market value and structure, consumer behaviour and preferences, as well as important legal regulations, trends and events that will have an impact on the OTC segment in 2017-2022.The report includes an Excel file with key underlying data, allowing you to sort and manage the data according to your needs – a useful tool particularly for analysts.
The report update is an Excel file containing updated figures plus a ‘Key Conclusions’ sheet with expert commentary about observed changes

A key part of the report comprises profiles of the largest manufacturers of OTC drugs and dietary supplements, as well as data regarding bestselling products in these two segments.

Subscription: 12 months
Publication date: September 2016
Other versions: Polish
Delivery: Online with easy export (PDF, PPT, XLS, DOC)
Sector: Pharma
Country: Poland
Pages: 349

Do you need assistance?

Phone: +48 12 340 51 30

Email: info@pmrcr.com

Description

Description

An analysis of the OTC market (over-the-counter market for dietary supplements and other products sold) developed by the PMR’s experts includes current market conditions, development forecasts, market value and structure, consumer behaviour and preferences, as well as important legal regulations, trends and events that will have an impact on the OTC segment in 2017-2022.The report includes an Excel file with key underlying data, allowing you to sort and manage the data according to your needs – a useful tool particularly for analysts.The report update is an Excel file containing updated figures plus a ‘Key Conclusions’ sheet with expert commentary about observed changes.

A key part of the report comprises profiles of the largest manufacturers of OTC drugs and dietary supplements, as well as data regarding bestselling products in these two segments.

 

What is the content of the report?

 

  • A broad range of analyses and forecasts: OTC drugs, dietary supplements, entire OTC market, pharmacy sales, non-pharmacy sales
  • Value and development forecasts for 2017-2022 for the Polish OTC market, along with expert explanation and analysis of forecasts
  • Market value and growth forecasts for the major therapeutic categories: cold and flu remedies, vitamins, minerals and nutrients, analgesics, antacids, products used to treat cardiovascular diseases and products intended for cutaneous use.
  • An extensive collation of market data, including market share of the pharmacy and non-pharmacy OTC segments, share of OTC drugs, dietary supplements and cosmetics in the pharmaceutical and pharmacy market, prices of OTC products, market shares of the largest OTC products and dietary supplements manufacturers
  • Overview of OTC products distribution channels
  • Consumer trends and producer trends (e.g. acquisitions, mergers, product portfolio extensions) that affect the market situation and development
  • Examples of Rx-OTC and OTC-Rx product switches over the last few years
  • Bestselling OTC drugs and dietary supplements
  • Detailed profiles of the major players in the OTC market, including an analysis of their portfolios, financial performance, ownership structure and advertising expenditure, as well as investments planned
  • Analysis of OTC product advertising in all major channels, including the most frequently advertised products, major advertisers, marketing strategies, spending on advertising and forms of OTC product advertising
  • Consumer behaviour and preferences regarding the selection, purchase and use of OTC medicines and dietary supplements
  • The latest and planned legal regulations related to the manufacture and sales of OTC products in Poland.

 

Who benefits from the analysis? 

 

  • Companies manufacturing OTC drugs and dietary supplements
  • Businesses specialising in pharmacy sales of OTC products and dietary supplements
  • Entities engaged in online and non-pharmacy distribution of OTC drugs and dietary supplements in Poland
  • Advertising agencies operating in the pharmaceutical industry
  • Private equity funds, financial institutions
  • Research and academic institutions
  • Business consultants
  • Embassies, government agencies, industry organisations, banks.

 

 Why to buy the report?

 

The report on the OTC market is especially helpful in the following situations:

  • regular monitoring of development and changes taking place in the OTC market with a view to flexible adjustment of policies and portfolios to the market events and trends
  • planning a new investment or making decisions regarding financial support for entities operating in the market
  • development of a product portfolio – identification of categories showing the highest growth prospects and already saturated segments
  • analysis of investment and credit risk in the market
  • performing mergers and acquisitions – identification of the most prospective market areas and entities/brands to be taken over
  • analysis of competitors’ current business operations, performance and plans – a quick reaction allowing to keep or increase one’s market share
  • elaborating corporate development strategies and budgets based on original market development forecasts prepared by the team of econometricians and market analysts
  • comparison of OTC distribution channels and development of the distribution strategy owing to a comparative analysis based on data and forecasts regarding each OTC segment
  • estimating demand for individual categories of OTC products now and in the future
  • launching business operations in new market segments
  • essential tool for developing price policies owing to price analysis.

What is the content of the report?

  • A broad range of analyses and forecasts: OTC drugs, dietary supplements, entire OTC market, pharmacy sales, non-pharmacy sales
  • Value and development forecasts for 2017-2022 for the Polish OTC market, along with expert explanation and analysis of forecasts
  • Market value and growth forecasts for the major therapeutic categories: cold and flu remedies, vitamins, minerals and nutrients, analgesics, antacids, products used to treat cardiovascular diseases and products intended for cutaneous use.
  • An extensive collation of market data, including market share of the pharmacy and non-pharmacy OTC segments, share of OTC drugs, dietary supplements and cosmetics in the pharmaceutical and pharmacy market, prices of OTC products, market shares of the largest OTC products and dietary supplements manufacturers
  • Overview of OTC products distribution channels
  • Consumer trends and producer trends (e.g. acquisitions, mergers, product portfolio extensions) that affect the market situation and development
  • Examples of Rx-OTC and OTC-Rx product switches over the last few years
  • Bestselling OTC drugs and dietary supplements
  • Detailed profiles of the major players in the OTC market, including an analysis of their portfolios, financial performance, ownership structure and advertising expenditure, as well as investments planned
  • Analysis of OTC product advertising in all major channels, including the most frequently advertised products, major advertisers, marketing strategies, spending on advertising and forms of OTC product advertising
  • Consumer behaviour and preferences regarding the selection, purchase and use of OTC medicines and dietary supplements
  • The latest and planned legal regulations related to the manufacture and sales of OTC products in Poland.

 

Who benefits from the analysis?

  • Companies manufacturing OTC drugs and dietary supplements
  • Businesses specialising in pharmacy sales of OTC products and dietary supplements
  • Entities engaged in online and non-pharmacy distribution of OTC drugs and dietary supplements in Poland
  • Advertising agencies operating in the pharmaceutical industry
  • Private equity funds, financial institutions
  • Research and academic institutions
  • Business consultants
  • Embassies, government agencies, industry organisations, banks.

 

Why to buy the report?

The report on the OTC market is especially helpful in the following situations:

  • regular monitoring of development and changes taking place in the OTC market with a view to flexible adjustment of policies and portfolios to the market events and trends
  • planning a new investment or making decisions regarding financial support for entities operating in the market
  • development of a product portfolio – identification of categories showing the highest growth prospects and already saturated segments
  • analysis of investment and credit risk in the market
  • performing mergers and acquisitions – identification of the most prospective market areas and entities/brands to be taken over
  • analysis of competitors’ current business operations, performance and plans – a quick reaction allowing to keep or increase one’s market share
  • elaborating corporate development strategies and budgets based on original market development forecasts prepared by the team of econometricians and market analysts
  • comparison of OTC distribution channels and development of the distribution strategy owing to a comparative analysis based on data and forecasts regarding each OTC segment
  • estimating demand for individual categories of OTC products now and in the future
  • launching business operations in new market segments
  • essential tool for developing price policies owing to price analysis.

 

Table of Contents

Table of Contents

  • Methodology
  • Executive summary
  • Overview of the OTC market and development forecasts until 2022
    • Key events and trends on the OTC market
      • Key events and trends in 2016-2017
      • Expected events and trends in 2017-2022
    • Pharmacy and non-pharmacy market of OTC drugs and dietary supplements
      • Sales value in 2015-2016 and development forecasts for 2017-2022
      • Market structure by sales channels and product status
    • Pharmacy market of OTC products
      • Sales value in 2014-2016 and development forecasts for 2017-2022
      • Market structure by product status
      • OTC segment share in the pharmaceutical market
    • Non-pharmacy market of OTC drugs and dietary supplements
      • Sales value in 2015-2016 and development forecasts for 2017-2022
      • Market structure by product status
      • Main therapeutic categories
    • Pharmacy and non-pharmacy market of OTC drugs
      • Sales value in 2015-2016 and development forecasts for 2017-2022
      • Market structure by distribution channels
      • Main therapeutic categories
    • Pharmacy and non-pharmacy market of dietary supplements
      • Sales value in 2014-2016 and development forecasts for 2017-2022
      • Market structure by distribution channels
      • Main therapeutic categories
    • Pharmacy market of dermocosmetics
      • Sales value in 2012-2016 and development forecasts for 2017-2022
      • Main therapeutic categories
    • Prices of OTC products
      • OTC products
      • OTC drugs
      • Dietary supplements
      • Dermocosmetics
  • Key events and trends on the OTC market
    • Key events and trends in 2016-2017
    • Expected events and trends in 2017-2022
  • Key events and trends in 2016-2017
  • Expected events and trends in 2017-2022
  • Pharmacy and non-pharmacy market of OTC drugs and dietary supplements
    • Sales value in 2015-2016 and development forecasts for 2017-2022
    • Market structure by sales channels and product status
  • Sales value in 2015-2016 and development forecasts for 2017-2022
  • Market structure by sales channels and product status
  • Pharmacy market of OTC products
    • Sales value in 2014-2016 and development forecasts for 2017-2022
    • Market structure by product status
    • OTC segment share in the pharmaceutical market
  • Sales value in 2014-2016 and development forecasts for 2017-2022
  • Market structure by product status
  • OTC segment share in the pharmaceutical market
  • Non-pharmacy market of OTC drugs and dietary supplements
    • Sales value in 2015-2016 and development forecasts for 2017-2022
    • Market structure by product status
    • Main therapeutic categories
  • Sales value in 2015-2016 and development forecasts for 2017-2022
  • Market structure by product status
  • Main therapeutic categories
  • Pharmacy and non-pharmacy market of OTC drugs
    • Sales value in 2015-2016 and development forecasts for 2017-2022
    • Market structure by distribution channels
    • Main therapeutic categories
  • Sales value in 2015-2016 and development forecasts for 2017-2022
  • Market structure by distribution channels
  • Main therapeutic categories
  • Pharmacy and non-pharmacy market of dietary supplements
    • Sales value in 2014-2016 and development forecasts for 2017-2022
    • Market structure by distribution channels
    • Main therapeutic categories
  • Sales value in 2014-2016 and development forecasts for 2017-2022
  • Market structure by distribution channels
  • Main therapeutic categories
  • Pharmacy market of dermocosmetics
    • Sales value in 2012-2016 and development forecasts for 2017-2022
    • Main therapeutic categories
  • Sales value in 2012-2016 and development forecasts for 2017-2022
  • Main therapeutic categories
  • Prices of OTC products
    • OTC products
    • OTC drugs
    • Dietary supplements
    • Dermocosmetics
  • OTC products
  • OTC drugs
  • Dietary supplements
  • Dermocosmetics
  • Market structure – main therapeutic categories
    • Cold and flu products
      • Growth drivers and barriers
      • Category value and development forecasts for 2017-2022
    • Vitamins, mineral and nutrition products
      • Growth drivers and barriers
      • Category value and development forecasts for 2017-2022
    • Analgesics
      • Growth drivers and barriers
      • Category value and development forecasts for 2017-2022
    • Gastric products
      • Growth drivers and barriers
      • Category value and development forecasts for 2017-2022
    • Products used for cardiovascular system disorders
      • Growth drivers and barriers
      • Category value and development forecasts for 2017-2022
    • Skin treatment products
      • Growth drivers and barriers
      • Category value and development forecasts for 2017-2022
  • Cold and flu products
    • Growth drivers and barriers
    • Category value and development forecasts for 2017-2022
  • Growth drivers and barriers
  • Category value and development forecasts for 2017-2022
  • Vitamins, mineral and nutrition products
    • Growth drivers and barriers
    • Category value and development forecasts for 2017-2022
  • Growth drivers and barriers
  • Category value and development forecasts for 2017-2022
  • Analgesics
    • Growth drivers and barriers
    • Category value and development forecasts for 2017-2022
  • Growth drivers and barriers
  • Category value and development forecasts for 2017-2022
  • Gastric products
    • Growth drivers and barriers
    • Category value and development forecasts for 2017-2022
  • Growth drivers and barriers
  • Category value and development forecasts for 2017-2022
  • Products used for cardiovascular system disorders
    • Growth drivers and barriers
    • Category value and development forecasts for 2017-2022
  • Growth drivers and barriers
  • Category value and development forecasts for 2017-2022
  • Skin treatment products
    • Growth drivers and barriers
    • Category value and development forecasts for 2017-2022
  • Growth drivers and barriers
  • Category value and development forecasts for 2017-2022
  • Rx-to-OTC and OTC-to-Rx switch strategies
    • Overview of the situation in Poland
    • Switch-related benefits and inconveniences
      • Benefits
      • Inconveniences
    • Examples of changes in availability categories of medicinal products on the Polish market in 2016-2017
      • Rx-to-OTC switch
      • Switch from OTC to Rx
    • Examples of the market value impact of the dispensing category change for selected active substances
      • Pantoprazole
      • Furaginum
      • Sildenafil
  • Overview of the situation in Poland
  • Switch-related benefits and inconveniences
    • Benefits
    • Inconveniences
  • Benefits
  • Inconveniences
  • Examples of changes in availability categories of medicinal products on the Polish market in 2016-2017
    • Rx-to-OTC switch
    • Switch from OTC to Rx
  • Rx-to-OTC switch
  • Switch from OTC to Rx
  • Examples of the market value impact of the dispensing category change for selected active substances
    • Pantoprazole
    • Furaginum
    • Sildenafil
  • Pantoprazole
  • Furaginum
  • Sildenafil
  • Bestselling products on the OTC market
    • OTC products
      • Cold and flu
      • Vitamins and minerals
      • Digestive tract and metabolism
      • Analgesics
      • Cardiovascular system
      • Dermatology and wounds treatment
    • OTC drugs
    • Dietary supplements
    • Dermocosmetics
  • OTC products
    • Cold and flu
    • Vitamins and minerals
    • Digestive tract and metabolism
    • Analgesics
    • Cardiovascular system
    • Dermatology and wounds treatment
  • Cold and flu
  • Vitamins and minerals
  • Digestive tract and metabolism
  • Analgesics
  • Cardiovascular system
  • Dermatology and wounds treatment
  • OTC drugs
  • Dietary supplements
  • Dermocosmetics
  • Largest players and their profiles
    • Sales value and market shares of the largest players
      • OTC products
      • OTC drugs
      • Dietary supplements
      • Dermocosmetics
    • Profiles of selected key players
      • Aflofarm
      • Bayer
      • GlaxoSmithKline
      • Hasco-Lek
      • Polpharma
      • Reckitt Benckiser
      • Sanofi
      • Teva
      • USP Zdrowie
      • Valeant Pharmaceuticals
    • Mergers and acquisitions
    • Stock market debuts
    • Expansion into foreign markets
    • Investment in the manufacturing sector
    • Planned expansion of the OTC product offer
  • Sales value and market shares of the largest players
    • OTC products
    • OTC drugs
    • Dietary supplements
    • Dermocosmetics
  • OTC products
  • OTC drugs
  • Dietary supplements
  • Dermocosmetics
  • Profiles of selected key players
    • Aflofarm
    • Bayer
    • GlaxoSmithKline
    • Hasco-Lek
    • Polpharma
    • Reckitt Benckiser
    • Sanofi
    • Teva
    • USP Zdrowie
    • Valeant Pharmaceuticals
  • Aflofarm
  • Bayer
  • GlaxoSmithKline
  • Hasco-Lek
  • Polpharma
  • Reckitt Benckiser
  • Sanofi
  • Teva
  • USP Zdrowie
  • Valeant Pharmaceuticals
  • Mergers and acquisitions
  • Stock market debuts
  • Expansion into foreign markets
  • Investment in the manufacturing sector
  • Planned expansion of the OTC product offer
  • Advertising of OTC products
    • General overview
      • Total spending
      • Spending by medium
      • Spending by category
      • Spending by manufacturer
    • TV advertising
      • Spending by manufacturer
    • Radio advertising
      • Spending by manufacturer
    • Press advertising
    • Online advertising
    • Advertising in pharmaceutical flyers
      • Total spending
      • Number of advertisements by category
      • Number of advertisements by manufacturer
      • Number of advertisements by product
  • General overview
    • Total spending
    • Spending by medium
    • Spending by category
    • Spending by manufacturer
  • Total spending
  • Spending by medium
  • Spending by category
  • Spending by manufacturer
  • TV advertising
    • Spending by manufacturer
  • Spending by manufacturer
  • Radio advertising
    • Spending by manufacturer
  • Spending by manufacturer
  • Press advertising
  • Online advertising
  • Advertising in pharmaceutical flyers
    • Total spending
    • Number of advertisements by category
    • Number of advertisements by manufacturer
    • Number of advertisements by product
  • Total spending
  • Number of advertisements by category
  • Number of advertisements by manufacturer
  • Number of advertisements by product
  • Consumer behaviour
    • Profile of a consumer who buys OTC drugs
      • Frequency of purchases by location
      • Frequency of purchases by gender
      • Frequency of purchases by age
      • Frequency of purchases by income
      • Frequency of purchases by place of residence
    • Profile of a consumer who buys dietary supplements
      • Frequency of purchases by location
      • Frequency of purchases by gender
      • Frequency of purchases by age
      • Frequency of purchases by income
      • Frequency of purchases by place of residence
    • Profile of a consumer who buys dermocosmetics
      • Frequency of purchases by location
      • Frequency of purchases by gender
      • Frequency of purchases by age
      • Frequency of purchases by income
      • Frequency of purchases by place of residence
    • Tendency to self-treatment among Poles
    • Most popular categories
    • Average spending
    • Searching information online
      • Confidence in buying medications online
  • Profile of a consumer who buys OTC drugs
    • Frequency of purchases by location
    • Frequency of purchases by gender
    • Frequency of purchases by age
    • Frequency of purchases by income
    • Frequency of purchases by place of residence
  • Frequency of purchases by location
  • Frequency of purchases by gender
  • Frequency of purchases by age
  • Frequency of purchases by income
  • Frequency of purchases by place of residence
  • Profile of a consumer who buys dietary supplements
    • Frequency of purchases by location
    • Frequency of purchases by gender
    • Frequency of purchases by age
    • Frequency of purchases by income
    • Frequency of purchases by place of residence
  • Frequency of purchases by location
  • Frequency of purchases by gender
  • Frequency of purchases by age
  • Frequency of purchases by income
  • Frequency of purchases by place of residence
  • Profile of a consumer who buys dermocosmetics
    • Frequency of purchases by location
    • Frequency of purchases by gender
    • Frequency of purchases by age
    • Frequency of purchases by income
    • Frequency of purchases by place of residence
  • Frequency of purchases by location
  • Frequency of purchases by gender
  • Frequency of purchases by age
  • Frequency of purchases by income
  • Frequency of purchases by place of residence
  • Tendency to self-treatment among Poles
  • Most popular categories
  • Average spending
  • Searching information online
    • Confidence in buying medications online
  • Confidence in buying medications online
  • Distribution of OTC products in Poland
    • Wholesale distribution
      • Number and characteristic of pharmaceutical wholesalers
      • Wholesale of OTC products
    • Pharmacy distribution
      • Number of pharmacies and pharmacy chains
      • Sales of OTC products by chain and individual pharmacies
    • Online distribution
      • Number of online pharmacies
      • Sales of OTC products by online pharmacies and stores
    • Non-pharmacy distribution
      • Wholesale distribution
      • Retail distribution
  • Wholesale distribution
    • Number and characteristic of pharmaceutical wholesalers
    • Wholesale of OTC products
  • Number and characteristic of pharmaceutical wholesalers
  • Wholesale of OTC products
  • Pharmacy distribution
    • Number of pharmacies and pharmacy chains
    • Sales of OTC products by chain and individual pharmacies
  • Number of pharmacies and pharmacy chains
  • Sales of OTC products by chain and individual pharmacies
  • Online distribution
    • Number of online pharmacies
    • Sales of OTC products by online pharmacies and stores
  • Number of online pharmacies
  • Sales of OTC products by online pharmacies and stores
  • Non-pharmacy distribution
    • Wholesale distribution
    • Retail distribution
  • Wholesale distribution
  • Retail distribution
Graphs and Tables

Graphs and Tables

List of tables

  • Macroeconomic, supply-side and demand-side factors affecting the OTC market change in Poland, 2016-2022
  • Legal changes affecting the OTC market growth rate in Poland, 2016-2022
  • CAGR for individual categories of OTC products in the pharmacy market in Poland (%), 2017-2022
  • Most important events, reforms and market trends, and their impact on the OTC market in Poland, 2016-2017
  • Number of GIS notifications of the first market placement of dietary supplements in Poland, 2013-2016
  • Parallel imports of medicinal products admitted for trading in Poland, 2016
  • Parallel imports of medicinal products admitted for trading in Poland, January-April 2017
  • Number and share (%) of parallel import licences for import to Poland of OTC drugs, by ATC category, 2016
  • Number and share (%) of parallel import licences for import to Poland of OTC drugs, by ATC category, January-April 2017
  • Future market reforms and changes, and their impact on the OTC market in Poland, 2017-2022
  • Restrictions on advertising of OTC drugs and dietary supplements which are likely to be introduced in Poland, 2018-2022
  • Pharmacy sales of selected OTC drug categories in Poland, by value (PLN m), 2015-2016
  • Pharmacy sales of selected OTC drug categories in Poland, by volume (million), 2015-2016
  • Sales value (PLN m) and market share (%) of main dietary supplement categories in Poland, 2016
  • Selected key categories of dermocosmetics in Poland, by sales value (PLN m), 2015 – Q1-Q3 2016
  • Selected key categories of dermocosmetics in Poland, by number of packages sold ('000), 2015 – Q1-Q3 2016
  • Pharmacy sales of selected OTC product categories in Poland (PLN m) and change (%), 2016
  • CAGR for individual categories of OTC products in the pharmacy market in Poland (%), 2017-2022
  • Growth stimulants and barriers for pharmacy sales of OTC cold and flu drugs and other products in Poland, 2017-2022
  • Growth stimulants and barriers for pharmacy sales of OTC drugs and other vitamins, mineral and nutrition products in Poland, 2017-2022
  • Growth stimulants and barriers for pharmacy sales of OTC analgesic drugs and other products in Poland, 2017-2022
  • Growth stimulants and barriers for pharmacy sales of OTC gastric drugs and other products in Poland, 2017-2022
  • Growth stimulants and barriers for pharmacy sales of OTC drugs and other products used for cardiovascular system disorders in Poland, 2017-2022
  • Growth stimulants and barriers for pharmacy sales of OTC skin treatment drugs and other products in Poland, 2017-2022
  • Switches in the availability category from Rx to OTC in Poland, 2016
  • Switches in the availability category from Rx to OTC in Poland, January-May 2017
  • OTC drugs with pantoprazole international name available in Poland, 2017
  • OTC drugs with furaginum/furazidin international name available in Poland, 2017
  • OTC drugs with sildenafil international name available in Poland, 2017
  • 30 bestselling OTC cold preparations in Poland, by sales value, 2016
  • 30 bestselling OTC vitamins in Poland, by sales value, 2016
  • Nine bestselling OTC vitamins having a drug status in Poland, by sales value, 2016
  • 30 bestselling OTC mineral products in Poland, by sales value, 2016
  • Five bestselling OTC minerals having a drug status in Poland, by sales value, 2016
  • 30 bestselling OTC preparations enhancing metabolism and digestive system functions in Poland, by sales value, 2016
  • 30 bestselling OTC analgesic products in Poland, by sales value, 2016
  • 30 bestselling OTC preparations supporting cardiovascular system in Poland, by sales value, 2016
  • 29 bestselling OTC dermatological products in Poland, by sales value, 2016
  • 29 bestselling OTC drugs in Poland, by sales value, 2016
  • Sales value of bestselling dietary supplements in pharmacies in Poland, share and change, 2016
  • 20 bestselling dermocosmetics in pharmacies in Poland, by estimated sales value (PLN m), Q1-Q3 2016
  • Sales value and change for 10 largest manufacturers on the pharmacy OTC product market in Poland, 2016
  • Market share of 10 largest manufacturers on the pharmacy OTC product market in Poland, by value (%), 2012 and April 2016-March 2017
  • Market share of the largest manufacturers on the pharmacy OTC drugs market in Poland, by value (%), 2015-2016
  • Sales value and change for the largest manufacturers on the pharmacy OTC drugs market in Poland, 2016
  • Pharmacy sales value (PLN m) for 15 largest manufacturers on the dietary supplements market in Poland and change (%), 2015-2016
  • Sales value (PLN m) and market share (%) for the largest manufacturers on the pharmacy dermocosmetics market in Poland, 2015 – Q1-Q3 2016
  • Ownership structure of Aflofarm Farmacja Polska Sp. z o.o. in Poland, 2017
  • General information about Aflofarm in Poland, 2017
  • Structure of Aflofarm in Poland, 2017
  • OTC product portfolio of Aflofarm in Poland, 2017
  • Ownership structure of Bayer in Poland, 2017
  • General information about Bayer in Poland, 2017
  • OTC product portfolio of Bayer Consumer Health in Poland, 2017
  • Ownership structure of GlaxoSmithKline in Poland, 2017
  • General information about GlaxoSmithKline in Poland, 2017
  • Structure of GlaxoSmithKline in Poland, 2017
  • OTC product portfolio of GlaxoSmithKline in Poland, 2017
  • Ownership structure of Hasco Group in Poland, 2017
  • General information about Hasco Group in Poland, 2017
  • Structure of the Hasco Group in Poland, 2017
  • OTC product portfolio of Hasco-Lek in Poland, 2017
  • Ownership structure of Polpharma Group in Poland, 2017
  • General information about Polpharma Group in Poland, 2017
  • Structure of Polpharma Group in Poland, 2017
  • OTC product portfolio of Polpharma in Poland, 2017
  • OTC product portfolio of Polfa Warszawa in Poland, 2017
  • Ownership structure of Reckitt Benckiser in Poland, 2017
  • General information about Reckitt Benckiser in Poland, 2017
  • Structure of Reckitt Benckiser in Poland, 2017
  • OTC product portfolio of Reckitt Benckiser in Poland, 2017
  • Ownership structure of Sanofi Group in Poland, 2017
  • General information about Sanofi Group in Poland, 2017
  • Structure of Sanofi Group in Poland, 2017
  • OTC product portfolio of Sanofi Group in Poland, 2016
  • Ownership structure of Teva in Poland, 2017
  • General information about Teva in Poland, 2017
  • Structure of Teva in Poland, 2017
  • Detailed OTC product portfolio of Teva in Poland, 2017
  • Ownership structure of USP Zdrowie in Poland (%), 2017
  • General information about USP Zdrowie in Poland, 2017
  • Structure of USP Zdrowie in Poland, 2017
  • OTC product portfolio of USP Zdrowie in Poland, 2017
  • OTC product portfolio of Naturell, June 2017
  • Ownership structure of Valeant in Poland (%), 2016
  • General information about Valeant Group in Poland, 2017
  • Structure of Valeant Group in Poland, 2016
  • Detailed OTC product portfolio of Valeant Pharmaceuticals in Poland, 2017
  • Selected mergers and acquisitions of companies in the OTC segment in Poland, 2015-June 2017
  • Possible acquisitions in the OTC segment in Poland, 2017+
  • Stock market debuts of companies from the OTC sector in Poland, 2015-2017
  • Selected past and future foreign investments of Polish OTC companies, 2016-2017
  • Selected investment in the OTC manufacturing sector in Poland, 2015-2017
  • Selected planned investment in the OTC manufacturing sector in Poland, 2016-2024
  • Expansion of the OTC product portfolio planned by manufacturers in Poland, 2016+
  • Promotional spending on OTC products in Poland (PLN m) and change (%), by segment, March 2015-February 2017
  • Change in the value of advertising expenditure on pharmaceuticals and drugs in Poland (PLN m) and growth rate (%), by traditional media channel, 2016
  • Share of advertising expenditure on pharmaceuticals in total advertising spending in Poland (%), 2015-H1 2016
  • Structure of promotional spending on OTC products in Poland (%), by segment, 2016
  • Largest advertisers from the pharmaceutical sector in non-internet media in Poland, January-April 2016-2017
  • 10 most frequently advertised brands of pharmaceutical products in Poland (%), Q1-Q3 2016
  • Expenditure on TV advertising by most active advertisers from the pharmaceutical sector in Poland (PLN m), 2016
  • Expenditure on TV advertising by most active advertisers from the pharmaceutical sector in Poland (PLN m) and change (%), Q1 2016-2017
  • GRP for selected pharmaceutical manufacturers on television in Poland, Q1 2016-2017
  • Expenditure on radio advertising of selected pharma industry manufacturers in Poland (PLN m), 2013-2014 and January-July 2015-2016
  • Estimated expenditure of the pharmaceutical industry on online advertising (PLN m) and share in total online advertising market (%), 2016
  • Number of advertisements in pharmaceutical flyers in Poland and change (%), by category, 2015-2016
  • Number of advertisements in pharmaceutical flyers in Poland and change (%), by category, Q1 2016-2017
  • Largest advertisers in pharmaceutical flyers in Poland, by number of adverts, 2015-2016
  • Brands most frequently advertised in pharmaceutical flyers in Poland, by number of adverts, 2015-2016
  • Frequency of buying OTC drugs in Poland (%), by purchase location and age, 2017
  • Frequency of buying OTC drugs in Poland (%), by purchase location and income, 2017
  • Frequency of purchasing dietary supplements in Poland (%), by purchase location and age, 2017
  • Frequency of purchasing dietary supplements in Poland (%), by purchase location and income, 2017
  • Frequency of purchasing dermocosmetics in Poland (%), by purchase location and age, 2017
  • Frequency of purchasing dermocosmetics in Poland (%), by purchase location and income, 2017
  • Share of individual dermocosmetics categories purchased in Poland (%), 2014-2016
  • Frequency of buying drugs and medical accessories online in Poland (%), in comparison with other medical services available via internet, September 2016
  • Comparison of CAGR for the market value and amount of margin in chain pharmacies 50+ and in the entire pharmacy market in Poland (%), 2010-2016
  • Comparison of the average value of the basket of 50 most popular OTC products in pharmacies in Poland (PLN), November 2015-2016
  • Declaration of OTC product purchases in 2016 in Poland, in total and by sales channel (%), 2017
  • Draft list of substances authorised for marketing in general stores and specialist medical supply shops in Poland, 2017


List of graphs

 

  • Value (PLN bn) and change (%) of the OTC drugs and dietary supplements market in Poland, 2015-2022
  • Value (PLN bn) and change (%) of the pharmacy market of OTC drugs and dietary supplements in Poland, 2014-2022
  • Value (PLN bn) and change (%) of the pharmacy market of OTC products in Poland, 2009-2022
  • Value (PLN bn) and change (%) of the non-pharmacy market of OTC products in Poland, 2015-2022
  • Number of OTC drugs authorised for marketing and dietary supplements notified in Poland, 2007 – January-April 2017
  • Incidence of flu in Poland (million), 2008 – January-May 2017
  • Proportion of Poles taking flu vaccinations in Poland (%), 2009/2010-2015/2016
  • Value (PLN bn) and change (%) of the OTC drugs and dietary supplements market in Poland, 2015-2022
  • OTC products market in Poland, by product status and value share (%), 2015-2016
  • OTC products market in Poland, by sales channel and value share (%), 2015-2016
  • Value (PLN bn) and change (%) of the pharmacy market of OTC drugs and dietary supplements in Poland, 2014-2022
  • Value (PLN bn) and change (%) of the pharmacy market of OTC products in Poland, 2009-2022
  • Pharmacy market of OTC products in Poland, by product status, in terms of value (%), 2014-2016
  • Pharmacy market of OTC products in Poland, by product status, in terms of number of packages sold (%), 2014-2016
  • Share of OTC products in the pharmaceutical market in Poland (%), 2009-Q1 2017
  • Value (PLN bn) and change (%) of the non-pharmacy market of OTC products in Poland, 2015-2022
  • Value (PLN bn) and change (%) of the non-pharmacy market of OTC drugs in Poland, 2015-2022
  • Value (PLN bn) and change (%) of the non-pharmacy market of dietary supplements in Poland, 2015-2022
  • Non-pharmacy sales of OTC products in Poland, by product status and value share (%), 2015-2016
  • Share of main therapeutic categories of OTC drugs in the non-pharmacy market in Poland, by value (%), 2015-2016
  • Share of main therapeutic categories of OTC drugs in the non-pharmacy market in Poland, by volume (%), 2015-2016
  • Value (PLN bn) and change (%) of the OTC drugs market in Poland, 2015-2022
  • OTC drugs market in Poland, by sales channel and value share (%), 2015-2016
  • OTC drugs market in Poland, by sales channel and volume share (%), 2015-2016
  • Value (PLN bn) and change (%) of the dietary supplements market in Poland, 2014-2022
  • Dietary supplements market in Poland, by sales channel and value share (%), 2015
  • Dietary supplements market in Poland, by sales channel and value share (%), 2016
  • Sales value change for selected categories of dietary supplements in Poland (%), 2016
  • Value (PLN bn) and change (%) of the dermocosmetics market in Poland, 2012-2022
  • Average pharmacy margin on OTC products in Poland, compared with other products (%), 2013-Q1 2017
  • Average prices of OTC products per packet in Poland (PLN) and change (%), 2012-Q1 2017
  • Average price of OTC drugs per packet in Poland (PLN) and change (%), 2009-2016
  • Average price of dietary supplements per packet in Poland (PLN) and change (%), 2009-2016
  • Average price of dermocosmetics per packet in Poland (PLN) and change (%), 2012-2016
  • Share of individual categories of OTC products in the pharmacy market in Poland (%), 2012-2016
  • Sales value of flu and cold OTC products in Poland (PLN bn) and change (%), 2012-2022
  • Sales value of vitamins, minerals and nutrition OTC products in Poland (PLN bn) and change (%), 2012-2022
  • Sales value of OTC analgesics in Poland (PLN bn) and change (%), 2012-2022
  • Sales value of OTC gastric products in Poland (PLN bn) and change (%), 2012-2022
  • Sales value of OTC products used for cardiovascular disorders in Poland (PLN bn) and change (%), 2012-2022
  • Sales value of OTC skin treatment products in Poland (PLN bn) and change (%), 2012-2022
  • Number of changes of status from prescription drug to OTC medication in Poland, 2009 – January-May 2017
  • Number of changes of status of an OTC drug to a prescription drug in Poland, 2010 – January-May 2017
  • Pharmacy consumers buying ellaOne tablets in Poland (%), by age, 2016
  • Share of top 10 bestselling products in total sales in the market of OTC drugs and dietary supplements in Poland (%), 2016
  • Value share of top 10 bestselling products in total OTC products sales in Poland, by category (%), 2016
  • Market share of 15 largest manufacturers on the pharmacy dietary supplement market in Poland, by value (%), 2015-2016
  • Product structure for Aflofarm in Poland, by number of products in specific categories (%), May 2017
  • Revenues and net profit for Aflofarm Farmacja Polska (PLN m), 2007-2014
  • Revenues and net profit/loss of Bayer Sp. z o.o. (PLN m), 2007-2015
  • Product structure for GlaxoSmithKline in Poland, by number of products in specific categories (%), May 2017
  • Revenues and net profit of GlaxoSmithKline Pharmaceuticals SA (PLN m), 2008-2014
  • Revenues and net profit of GSK Services Sp. z o.o. (PLN m), 2007-2015
  • Revenues and net profit of GlaxoSmithKline Consumer Healthcare Sp. z o.o. (PLN m), 2007-2015
  • Revenues and net profit/loss of GSK Commercial Sp. z o.o. (PLN m), 2007-2015
  • Product structure for PPF Hasco-Lek in Poland, by number of products in specific categories (%), May 2017
  • Revenues and net profit/loss for PPF Hasco-Lek SA (PLN m), 2007-2015
  • Revenues and net profit/loss for PCF Procefar Sp. z o.o. (PLN m), 2007-2015
  • Revenues and net profit/loss for CF Hasco-Lek Sp. z o.o. (PLN m), 2013-2015
  • Product structure for Polpharma in Poland, by number of products in specific categories (%), May 2017
  • Product structure for Polfa Warszawa in Poland, by number of products in specific categories (%), May 2017
  • Revenues and net profit of Zaklady Farmaceutyczne Polpharma SA (PLN m), 2007-2015
  • Revenues and net profit of Polpharma Biuro Handlowe Sp. z o.o. (PLN m), 2008-2015
  • Revenues and net profit of Warszawskie Zaklady Farmaceutyczne Polfa SA (PLN m), 2008 – Q1-Q3 2015
  • Revenues and net profit of Medana Pharma SA (PLN m), 2008-2015
  • Revenues and net profit for Reckitt Benckiser Production Poland Sp. z o.o. (PLN m), 2008-2015
  • Revenues and net profit for Reckitt Benckiser Poland SA (PLN m), 2008-2015
  • Product structure for Sanofi Group in Poland, by number of products in specific categories (%), May 2017
  • Revenues and net profit for Sanofi-Aventis Sp. z o.o. (PLN m), 2008-2015
  • Revenues and net profit for Sanofi Pasteur Sp. z o.o. (PLN m), 2008-2015
  • Revenues and net profit/loss for Nepentes Pharma Sp. z o.o. (PLN m), 2011-2015
  • Revenues and net profit/loss for Teva Operations Poland Sp. z o.o. (PLN m), 2007-2015
  • Revenues and net profit/loss for Teva Pharmaceuticals Polska Sp. z o.o. (PLN m), 2006-2015
  • Product structure for USP Zdrowie in Poland, by number of products in specific categories (%), May 2017
  • Product structure for Naturell in Poland, by number of products in specific categories (%), June 2017
  • Revenues and net profit of USP Zdrowie Sp. z o.o. (PLN m), 2011-2015
  • Revenues and net profit of US Pharmacia Sp. z o.o. (PLN m), 2009-2015
  • Product structure for Valeant Pharmaceuticals in Poland, by number of products in specific categories (%), May 2017
  • Revenues and net profit for ICN Polfa Rzeszow SA (PLN m), 2009-2015
  • Revenue and net profit for VP Valeant Sp. z o.o. Sp. j. (PLN m), 2012-2014
  • Revenue and net loss for Valeant Sp. z o.o. Sp. j. (PLN m), 2013-2014
  • Revenues and net profit for PF Jelfa SA (PLN m), 2009-2015
  • Revenues and net profit for Emo-Farm Sp. z o.o. (PLN m), 2008-2015
  • Advertising expenditure on pharmaceuticals and drugs in traditional media in Poland (PLN m) and change (%), 2015-Q1 2017
  • Promotional spending on OTC products in Poland, by promotion type (%), March 2016-February 2017
  • Share of individual media in real advertising expenditure by the pharma industry in Poland (%), Q1 2017
  • Categories of pharmaceuticals most frequently advertised in Poland (%), Q1 2017
  • Share of the number of OTC drugs and parapharmaceuticals advertisements in Poland (%), by category, 2015
  • Share of television advertisement in advertising budgets of selected largest pharmaceutical advertisers in Poland (%), Q1 2017
  • Value of the advertising market of product flyers in the pharma industry (PLN m) in Poland, 2015-2016
  • Location for purchases of over-the-counter drugs in 2016 in Poland (%), 2017
  • Structure of population buying OTC drugs in Poland (%), by gender, 2017
  • Structure of population buying OTC drugs in Poland (%), by age, 2017
  • Structure of population buying OTC drugs in Poland (%), by income, 2017
  • Structure of population buying OTC drugs in Poland (%), by place of residence, 2017
  • Proportion of Poles declaring purchases of dietary supplements in 2016 (%), 2017
  • Location for purchases of supplements in 2016 in Poland (%), 2017
  • Structure of population buying dietary supplements in Poland (%), by gender, 2017
  • Structure of population buying dietary supplements in Poland (%), by age, 2017
  • Structure of population buying dietary supplements in Poland (%), by income, 2017
  • Structure of population buying dietary supplements in Poland (%), by place of residence, 2017
  • Proportion of Poles declaring purchases of dermocosmetics in 2016 (%), 2017
  • Location for purchases of dermocosmetics in 2016 in Poland (%), 2017
  • Structure of population buying dermocosmetics in Poland (%), by gender, 2017
  • Structure of population buying dermocosmetics in Poland (%), by age, 2017
  • Structure of population buying dermocosmetics in Poland (%), by income, 2017
  • Frequency of buying dermocosmetics in Poland (%), by place of residence, 2017
  • Reaction to first symptoms of a disease in Poland (%), 2016
  • Disorders most frequently self-treated by Poles (%), 2016
  • Self-medication methods most frequently used by Poles (%), 2016
  • OTC products used at least once by Poles in the 12 months preceding the survey (%), by indication, September 2010-2016
  • Most frequent reasons for taking dietary supplements in Poland (%), February 2017
  • Average monthly spending on OTC drugs and dietary supplements in Poland (PLN), by gender, September 2016
  • Average monthly spending on OTC drugs and dietary supplements in Poland (PLN), by age, September 2016
  • Average monthly spending on OTC drugs and dietary supplements in Poland (PLN), by place of residence, September 2016
  • Frequency of checking online in Poland information and opinions on the action of an OTC drug used for the first time (%), 2016
  • Proportion of Poles who find buying drugs online risky, as it is not sure what is actually purchased (%), September 2016
  • Proportion of Poles who find buying drugs online risky, as it is not sure what is actually purchased, by internet users and non-users (%), September 2016
  • Number of pharmaceutical wholesale warehouses in Poland, August 2007-May 2017
  • Location of pharmaceutical wholesale warehouses in Poland (%), by voivodship, May 2017
  • Number of pharmacy chains and number of pharmacies participating in chains in Poland, Q3 2006-February 2017
  • Percentage of pharmacies belonging to pharmacy chains in Poland (%), 2005-2006 and Q3 2008-Feb 2017
  • Selected largest pharmacy chains in Poland, by number of establishments, May 2017
  • Number of SKUs of OTC products available on the pharmacy market in Poland (%), April 2017
  • Comparison of sales growth rates for 10 main therapeutic categories of OTC products in chain and independent pharmacies in Poland (%), 2016
  • Share of OTC products sales in total sales of pharmacy chains in Poland (%), 2010 and 2016
  • Share of OTC products sales in the amount of margin in chain pharmacies 50+ and in the entire pharmacy market in Poland (%), 2010-2016
  • Change for the number of OTC products in an average pharmacy in comparison with chain pharmacies in Poland (%), 2011-2016
  • Number of online pharmacies operating in Poland, May 2011-September 2016
  • Value structure of the online OTC market in Poland (%), by sales channel, 2016
  • Proportion of Poles declaring purchases of over-the-counter drugs in 2016 (%), 2017

 

Infographic

Infographic

Product details

Price:

3 000

Select languages:

Choose language

You don't have to wait. The content will be accessible online at the My PMR account.

Subscription: 12 months
Publication date: July 2017
Other versions: Polish
Delivery: Online with easy export (PDF, PPT, XLS, DOC)
Sector: Pharmaceuticals & Parapharmaceuticals
Country: Poland

Do you need assistance?

Phone: +48 12 340 51 30

Email: support@pmrcorporate.com

OTC market in Poland 2017

Market analysis and development forecasts 2017-2022

OTC market in Poland 2017

Get free excerpts, white papers and more info about PMR report.

Clients' Testimonials

 We are a long-standing subscriber of PMR’s information services, and specifically its pharmaceutical and healthcare market news bulletins.

We appreciate the reliability of the information provided,and the high standards of data analysis offered by PMR.    

Prezes Zarządu

PHOENIX Pharma Polska Sp. z o. o

I have been using PMR reports in my daily work for over 3 years. They are a source of consolidated knowledge based on the relevant indicators. At the same time I value our cooperation as an expert in the Health Care market in Poland. Your forecasts are important to us when working on marketing and promotional strategies.

Head of Sales and Marketing

Roche Diagnostic Polska Sp. z o.o.

Standard - license option entitles Client to make use of the product for a maximum of 2 persons indicated in the purchase process

Standard Plus - license option entitles Client to make use of the product for between 3 and 9 persons indicated in the purchase process

Corporate - license option entitles Client to make use of the product for between 10 and an unlimited number of persons indicated in the purchase process